{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:26:01Z","timestamp":1791300361946,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.yjmcc.2015.12.026","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T09:05:02Z","timestamp":1451379902000},"page":"72-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["DPP-4 inhibition has beneficial effects on the heart after myocardial infarction"],"prefix":"10.1016","volume":"91","author":[{"given":"Akihiko","family":"Kubota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tadokoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Kobara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Yamada-Inagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issei","family":"Komuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2015.12.026_bb0005","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4065\/mcp.2009.0494","article-title":"Chronic heart failure: contemporary diagnosis and management","volume":"85","author":"Ramani","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0010","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1172\/JCI39896","article-title":"Sonic hedgehog is a critical mediator of erythropoietin-induced cardiac protection in mice","volume":"120","author":"Ueda","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0015","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jacc.2012.01.064","article-title":"The year in heart failure","volume":"60","author":"Owens","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0020","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10741-012-9363-6","article-title":"Treatment for chronic heart failure in the elderly: current practice and problems","volume":"18","author":"Abete","year":"2013","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0025","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1161\/HYPERTENSIONAHA.110.158527","article-title":"Dipeptidyl peptidase IV inhibition alters the hemodynamic response to angiotensin-converting enzyme inhibition in humans with the metabolic syndrome","volume":"56","author":"Jackson","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0030","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.2174\/13816128113199990474","article-title":"Dipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protection","volume":"20","author":"Avogaro","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1475-2840-10-85","article-title":"Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure","volume":"10","author":"Yin","year":"2011","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0040","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1475-2840-12-154","article-title":"Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner","volume":"12","author":"Hausenloy","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0828-282X(10)70010-6","article-title":"The incretin system and cardiometabolic disease","volume":"26","author":"Szmitko","year":"2010","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0050","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/CIRCULATIONAHA.106.672451","article-title":"Stromal cell-derived factor-1 alpha confers protection against myocardial ischemia\/reperfusion injury: role of the cardiac stromal cell\u2013derived factor-1 alpha\u2013CXCR4 axis","volume":"116","author":"Hu","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0055","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/31261","article-title":"The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract","volume":"393","author":"Tachibana","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0060","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/CIRCULATIONAHA.112.096479","article-title":"Dipeptidyl peptidase-4 modulates left ventricular dysfunction in chronic heart failure via angiogenesis-dependent and -independent actions","volume":"126","author":"Shigeta","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2009.02.013","article-title":"Synergy between CD26\/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction","volume":"4","author":"Zaruba","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0070","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1139\/y2012-039","article-title":"MK-626, a dipeptidyl peptidase-4 inhibitor, does not improve the hyperglycemia or hyperinsulinemia of nonobese diabetic MKR mice. Can J","volume":"90","author":"Bhattacharjee","year":"2012","journal-title":"Physiol. Pharmacol."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbrc.2010.08.112","article-title":"Inhibition of dipeptidyl peptidase 4 regulates microvascular endothelial growth induced by inflammatory cytokines","volume":"401","author":"Takasawa","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0080","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1073\/pnas.1114931109","article-title":"Intestinal CX3C chemokine receptor 1(high) (CX3CR1(high)) myeloid cells prevent T-cell-dependent colitis","volume":"109","author":"Kayama","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054518","article-title":"DPP4 deficiency exerts protective effect against H2O2 induced oxidative stress in isolated cardiomyocytes","volume":"8","author":"Ku","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0090","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(03)14232-8","article-title":"Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy","volume":"362","author":"Askari","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0100","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1161\/CIRCULATIONAHA.107.694992","article-title":"Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction","volume":"117","author":"Saxena","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0105","doi-asserted-by":"crossref","first-page":"H1496","DOI":"10.1152\/ajpheart.00365.2011","article-title":"SDF-1\/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia\/reperfusion injury","volume":"301","author":"Huang","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nm1199","article-title":"G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-stat pathway in cardiomyocytes","volume":"11","author":"Harada","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0115","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10557-010-6263-7","article-title":"Cytokine combination therapy with erythropoietin and granulocyte colony stimulating factor in a porcine model of acute myocardial infarction","volume":"24","author":"Angeli","year":"2010","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0120","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.bcp.2011.11.028","article-title":"DPP-4 inhibitors in the treatment oftype 2 diabetes","volume":"83","author":"Duez","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0125","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/nm.2991","article-title":"Dipeptidyl peptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis","volume":"18","author":"Broxmeyer","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0130","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2337\/db09-0955","article-title":"Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice","volume":"59","author":"Sauv\u00e9","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0135","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1161\/CIRCULATIONAHA.107.739938","article-title":"Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor- dependent and -independent pathways","volume":"117","author":"Ban","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0145","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nm1075","article-title":"Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1","volume":"10","author":"Ceradini","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0150","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1158\/0008-5472.CAN-07-1589","article-title":"Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition","volume":"68","author":"Dang","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0155","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/CIRCHEARTFAILURE.110.960302","article-title":"Stromal cell-derived factor-1 retention and cardioprotection for ischemic myocardium","volume":"4","author":"Kanki","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0160","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.tips.2009.08.003","article-title":"Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?","volume":"30","author":"Yazbeck","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0165","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1152\/ajpheart.00365.2011","article-title":"SDF-1\/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia\/reperfusion injury","volume":"301","author":"Huang","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/cvr\/cvu034","article-title":"STAT3, a key regulator of cell-to-cell communication in the heart","volume":"102","author":"Haghikia","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0175","doi-asserted-by":"crossref","first-page":"592760","DOI":"10.1155\/2010\/592760","article-title":"Effects of sitagliptin treatment on dysmetabolisminflammation, and oxidative stress in an animal model of type 2 diabetes","volume":"2010","author":"Ferreira","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0180","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","volume":"369","author":"Scirica","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0185","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","article-title":"Kupfer S, Wilson C, Cushman WC, zannad F; EXAMINE investigators. Alogliptin after acute coronary syndrome in patients with type 2 diabetes","volume":"369","author":"White","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2015.12.026_bb0190","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa1501352","article-title":"Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes","volume":"373","author":"Green","year":"2015","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282815301656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282815301656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,4]],"date-time":"2021-04-04T17:20:09Z","timestamp":1617556809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282815301656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":36,"alternative-id":["S0022282815301656"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2015.12.026","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DPP-4 inhibition has beneficial effects on the heart after myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2015.12.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}